Jefferies Starts Incyte (INCY) at Buy, 'Extending Blockbuster Stories into Dermatology Beyond Jakafi'
Tweet Send to a Friend
(Updated - February 23, 2024 3:13 AM EST)Jefferies analyst Kelly Shi initiates coverage on Incyte (NASDAQ: INCY) with a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
